Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pharming Group N.V (PHAR) Assets Average: 2021-2025

Historic Assets Average for Pharming Group N.V (PHAR) over the last 5 years, with Sep 2025 value amounting to $460.0 million.

  • Pharming Group N.V's Assets Average rose 9.34% to $460.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $460.0 million, marking a year-over-year increase of 9.34%. This contributed to the annual value of $431.4 million for FY2024, which is 2.90% down from last year.
  • As of Q3 2025, Pharming Group N.V's Assets Average stood at $460.0 million, which was up 8.31% from $424.7 million recorded in Q2 2025.
  • In the past 5 years, Pharming Group N.V's Assets Average ranged from a high of $460.0 million in Q3 2025 and a low of $419,425 during Q1 2021.
  • Moreover, its 3-year median value for Assets Average was $426.4 million (2023), whereas its average is $430.4 million.
  • Data for Pharming Group N.V's Assets Average shows a peak YoY increase of 94,090.11% (in 2022) and a maximum YoY decrease of 51.49% (in 2022) over the last 5 years.
  • Over the past 5 years, Pharming Group N.V's Assets Average (Quarterly) stood at $399.1 million in 2021, then plummeted by 46.61% to $213.1 million in 2022, then soared by 111.02% to $449.7 million in 2023, then fell by 8.21% to $412.7 million in 2024, then grew by 9.34% to $460.0 million in 2025.
  • Its last three reported values are $460.0 million in Q3 2025, $424.7 million for Q2 2025, and $401.6 million during Q1 2025.